15.451 articles found

Subthalamic deep brain stimulation with a constant-current device in Parkinson's disease: an open-label randomised controlled trial.

Okun MS, Gallo BV, Mandybur G, Jagid J, Foote KD, Revilla FJ, Alterman R, Jankovic J, Simpson R, Junn F, Verhagen L, Arle JE, Ford B, Goodman RR, Stewart RM, Horn S, Baltuch GH, Kopell BH, Marshall F, Peichel D, Pahwa R, Lyons KE, Tröster AI, Vitek JL, Tagliati M, SJM DBS Study Group.

Lancet Neurol · 2012-01-11

DOI: 10.1016/s1474-4422(11)70308-8PMID: 22239915

Influence of risperidone on balance control in young healthy individuals.

Corbeil P, Rodrigue J, Simoneau M, Cohen H, Pourcher E.

Psychopharmacology (Berl) · 2012-01-11

DOI: 10.1007/s00213-011-2623-7PMID: 22234381

Clinical correlates of apathy in patients recently diagnosed with Parkinson's disease: the ANIMO study.

Cubo E, Benito-León J, Coronell C, Armesto D, ANIMO Study Group.

Neuroepidemiology · 2012-01-06

DOI: 10.1159/000334314PMID: 22236943

Abnormal activity in the precuneus during time perception in Parkinson's disease: an fMRI study.

Dušek P, Jech R, Sieger T, Vymazal J, Růžička E, Wackermann J, Mueller K.

PLoS One · 2012-01-06

DOI: 10.1371/journal.pone.0029635PMID: 22238630

Clinical application of stem cell therapy in Parkinson's disease.

Politis M, Lindvall O.

BMC Med · 2012-01-04

DOI: 10.1186/1741-7015-10-1PMID: 22216957

Deep brain stimulation of the subthalamic nucleus improves sense of well-being in Parkinson's disease.

McDonald LM, Page D, Wilkinson L, Jahanshahi M.

Mov Disord · 2012-01-04

DOI: 10.1002/mds.24035PMID: 22411848

A clinical and imaging study investigating pathophysiology of fatigue in Parkinson's disease

Metta VK.

· 2012-01-01

Complexity of motor response to different doses of duodenal levodopa infusion in Parkinson disease.

Nyholm D, Johansson A, Aquilonius SM, Hellquist E, Lennernäs H, Askmark H.

Clin Neuropharmacol · 2012-01-01

DOI: 10.1097/wnf.0b013e31823b1ffdPMID: 22094648

Clinical utility of screening for clinical depression and bipolar disorder.

Mitchell AJ.

Curr Opin Psychiatry · 2012-01-01

DOI: 10.1097/yco.0b013e32834de45bPMID: 22139723

Flexibility of Markov modeling for clinical pharmacoeconomics: illustration for cost-effectiveness in early Parkinson's disease.

Postma MJ, Boersma C.

Expert Rev Clin Pharmacol · 2012-01-01

DOI: 10.1586/ecp.11.69PMID: 22142151

Transcranial near-infrared laser therapy applied to promote clinical recovery in acute and chronic neurodegenerative diseases.

Lapchak PA.

Expert Rev Med Devices · 2012-01-01

DOI: 10.1586/erd.11.64PMID: 22145842

Treatment effect modifiers for the patient education programme for Parkinson's disease.

A'Campo LE, Wekking EM, Spliethoff-Kamminga NG, Stijnen T, Roos RA.

Int J Clin Pract · 2012-01-01

DOI: 10.1111/j.1742-1241.2011.02791.xPMID: 22171907